89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -367,079 | -142,189 | -102,026 | -90,122 | -49,499 |
| Depreciation Amortization | -9,103 | -5,318 | -151 | 1,561 | 558 |
| Income taxes - deferred | N/A | N/A | N/A | -150 | -69 |
| Accounts payable and accrued liabilities | 7,058 | -3,917 | 5,659 | 4,778 | 1,131 |
| Other Working Capital | -14,528 | 657 | 10,556 | 3,252 | -1,041 |
| Other Operating Activity | 15,829 | 21,581 | 4,872 | 3,900 | 2,676 |
| Operating Cash Flow | $-367,823 | $-129,186 | $-81,090 | $-76,781 | $-46,244 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -4 | -7 | -63 | -126 |
| Purchase Of Investment | -40,849 | -123,015 | -33,936 | 7,222 | -106,706 |
| Investing Cash Flow | $-40,864 | $-123,019 | $-33,943 | $7,159 | $-106,832 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,349 | 24,363 | N/A | 19,951 | N/A |
| Debt Repayment | N/A | -21,400 | N/A | N/A | N/A |
| Common Stock Issued | 212,137 | 512,423 | 118,129 | 3,920 | 158,085 |
| Other Financing Activity | -2,900 | -2,275 | -298 | 0 | -161 |
| Financing Cash Flow | $218,586 | $513,111 | $117,831 | $23,871 | $157,924 |
| Beginning Cash Position | 316,161 | 55,255 | 52,457 | 98,208 | 93,360 |
| End Cash Position | 126,060 | 316,161 | 55,255 | 52,457 | 98,208 |
| Net Cash Flow | $-190,101 | $260,906 | $2,798 | $-45,751 | $4,848 |
| Free Cash Flow | |||||
| Operating Cash Flow | -367,823 | -129,186 | -81,090 | -76,781 | -46,244 |
| Capital Expenditure | -15 | -4 | -7 | -63 | -126 |
| Free Cash Flow | -367,838 | -129,190 | -81,097 | -76,844 | -46,370 |